Optimind pharma - Crunchbase Company Profile & Funding

Q: Where is Optimind pharma's headquarters?

Optimind pharma is located in London, Ontario, Canada.

Q: When was the last funding round for Optimind pharma?

Optimind pharma closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has Optimind pharma raised to date?

Optimind pharma has raised obfuscated.

Overview

Optimind pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Optimind pharma

CB Rank

214531

Optimind pharma is a provider of psychedelic therapies for the masses.

Founded

obfuscation

Public

Post-IPO Equity

London, Ontario, Canada

11-50

optimindpharma.com

Fitness

Wellness

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Details

Also Known As

Loon Energy Corporation

Operating Status

Active

Stock Symbol

CNSX:OMND

Company Type

For Profit

About the Company

Optimind Pharma is a provider of psychedelic therapies for the masses it helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities.

Contact Email

info@optimindpharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

Optimind pharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Products & Services

Ketamine-Assisted Therapy

A treatment program that combines the use of ketamine with psychotherapy to help alleviate symptoms of depression, anxiety, PTSD, and other mental health conditions.

Psilocybin Research and Development

An initiative to produce psilocybin for use in microdoses in clinics, aimed at qualified patients throughout North America.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Optimind pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Optimind pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Optimind pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Optimind pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Optimind pharma	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Optimind pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Optimind pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Optimind pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Optimind pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Optimind pharma	—	obfuscated obfuscation	—	Post-IPO Equity